~~<i id='F6C602FA38'><strike id='F6C602FA38'><tt id='F6C602FA38'><pre id='F6C602FA38'></pre></tt></strike></i>~~

Home» explore» entertainment

entertainment

author：fashion 2025-10-02 15:35:20 Page View：57

Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows.

On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups. The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz. He also has a track record at pharmaceutical companies like Novartis and Baxalta.

Bioluminescence joined at least four other firms — OrbiMed, Sofinnova Partners, Abingworth, and Revelation Partners — in announcing new pools of capital in the last two weeks. Together, they have raised $5.94 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alabama hospital puts IVF treatments on hold
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

leisure time

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

2:04ACanadairfirefightingplanesprayswaterduringafireinDervenochoria,north-westofAthens,onJuly19,2023

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

Texas Department of Public Safety speaks out on migrant abuse allegations

1:46Inanaerialview,migrantsseekingasylumreceiveinstructionsfromlawenforcementofficersinEaglePass,Tex